← FDA Drug Approvals (Drugs@FDA)

GRIFULVIN V

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VALEANT LUXEMBOURG · Approved 1980-06-02

Drug application

FDA Application #

ANDA062279

Application type

Abbreviated New Drug Application (Generic)

Brand name

GRIFULVIN V

Generic name

Griseofulvin, Microcrystalline

Active ingredients

GRISEOFULVIN, MICROCRYSTALLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

VALEANT LUXEMBOURG

First approval

1980-06-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown